Eagle Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$14.4M Sell
1,356,779
-580,930
-30% -$5.5M 0.07% 230
2024
Q2
$15.6M Buy
1,937,709
+1,386,691
+252% +$14.9M 0.08% 213
2024
Q1
$7.82M Buy
551,018
+100,562
+22% +$1.17M 0.04% 329
2023
Q4
$3.66M Buy
+450,456
New +$2.36M 0.02% 409
2020
Q4
Sell
-63,874
Closed -$2.06M 623
2020
Q3
$2.06M Sell
63,874
-644,786
-91% -$19.8M 0.01% 442
2020
Q2
$19.3M Buy
708,660
+275,325
+64% +$9.05M 0.11% 218
2020
Q1
$13M Buy
433,335
+107,353
+33% +$2.85M 0.08% 243
2019
Q4
$9.02M Buy
+325,982
New +$7.41M 0.04% 327

Other funds holding IOVA